Sunil Manjila

Sunil Manjila

Auto-generated profile, based on publicly available information

Sunil Manjila

Skull Base and Cerebrovascular SurgeryDepartment of NeurosurgeryHartford Hospital, Hartford, ConnecticutMidState Medical Center, Meriden, ConnecticutThe Hospital of Central Connecticut, New Britain, Connecticut

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2019 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
JOJ.M. Ospel
J.M. Ospel
CWC.H. Wright
C.H. Wright
RJR. Jung
R. Jung
LVL.L.M. Vidal
L.L.M. Vidal
SMS. Manjila
S. Manjila
KBK.A. Blackham
K.A. Blackham
SUMMARY: Reversible vasoconstriction syndrome is a complex of clinical symptoms and angiographic findings, which, while having a mostly benign clinical course, has clinical and imaging overlap with more serious disorders such as vasculitis and aneurysmal SAH and itself includes a minority of patients with fulminant vasoconstriction resulting in severe intracranial complications. Endovascular options for patients with refractory reversible cerebral vasoconstriction syndrome include intra-arterial vasodilator infusion similar to therapy for patients with vasospasm after SAH. To date, only case reports and 1 small series have discussed the utility of intra-arterial vasodilators for the treatment of reversible cerebral vasoconstriction syndrome. We report an additional series of 11 medically refractory cases of presumed or proved reversible cerebral vasoconstriction syndrome successfully treated with intra-arterial verapamil infusion. Furthermore, we propose that the reversal of vasoconstriction, as seen on angiography, could fulfill a diagnostic criterion.

20 January 2017 in Pediatric Neurosurgery
Verified
Journal Article
Closed access
SMSunil Manjila
Sunil Manjila
AKAditya Karhade
Aditya Karhade
JPJi Hoon Phi
Ji Hoon Phi
RSR. Michael Scott
R. Michael Scott
ESEdward R. Smith
Edward R. Smith
Background/Aims: Brain shift during the exposure of cranial lesions may reduce the accuracy of frameless stereotaxy. We describe a rapid, safe, and effective method to approach deep-seated brain lesions using real-time intraoperative ultrasound placement of a catheter to mark the dissection trajectory to the lesion. Methods: With Institutional Review Board approval, we retrospectively reviewed the radiographic, pathologic, and intraoperative data of 11 pediatric patients who underwent excision of 12 lesions by means of this technique. Results: Full data sets were available for 12 lesions in 11 patients. Ten lesions were tumors and 2 were cavernous malformations. Lesion locations included the thalamus (n = 4), trigone (n = 3), mesial temporal lobe (n = 3), and deep white matter (n = 2). Catheter placement was successful in all patients, and the median time required for the procedure was 3 min (range 2-5 min). There were no complications related to catheter placement. The median diameter of surgical corridors on postresection magnetic resonance imaging was 6.6 mm (range 3.0-12.1 mm). Conclusions: Use of real-time ultrasound guidance to place a catheter to aid in the dissection to reach a deep-seated brain lesion provides advantages complementary to existing techniques, such as frameless stereotaxy. The catheter insertion technique described here provides a quick, accurate, and safe method for reaching deep-seated lesions.

1 July 2013 in Journal of neurosurgery. Pediatrics
Verified
Journal Article
Closed access
PDF file
SMSunil Manjila
Sunil Manjila
EMErin Miller
Erin Miller
AAAmad Awadallah
Amad Awadallah
SMShunichi Murakami
Shunichi Murakami
MCMark L. Cohen
Mark L. Cohen
ACAlan R. Cohen
Alan R. Cohen
True ossification within benign brain tumors is rare, and the molecular mechanism for this process is poorly understood. The authors report a case of ossified choroid plexus papilloma (CPP) and analyze it to help elucidate the underlying molecular basis of osteogenesis in benign brain tumors. A 21-year-old man presented with headache and depression that progressed over years. Computed tomography, MRI, and angiography demonstrated a large heavily calcified fourth ventricular tumor with a vascular blush and no hydrocephalus. The tumor was resected and was found to be an ossified CPP. Immunohistochemical staining for VEGF, Sox2, BMP-2, osterix, osteopontin, and osteocalcin was performed in an attempt to elucidate the mechanism of bone formation. The tumor was extensively ossified with mature bone trabeculae. Immunostaining for VEGF was positive. Additional staining showed the presence of osteocalcin in this ossified tumor but not in samples of nonossified CPPs collected from other patients. Staining for osterix and osteopontin was equivocally positive in the ossified CPP but also in the nonossified CPPs examined. The presence of osteocalcin in the ossified CPP demonstrates that there is true bone formation rather than simple calcification. Its appearance within cells around the trabeculae suggests the presence of osteoblasts. The presence of osterix suggests that a pluripotent cell, or one that is already partially differentiated, may be differentiated into an osteoblast through this pathway. This represents the first systematic immunohistochemical analysis of osteogenesis within choroid plexus tumors.

2 July 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
SMS. Manjila
S. Manjila